Ultragenyx Pharma (RARE) Misses Q2 EPS by 2c

August 8, 2016 4:32 PM EDT
Get Alerts RARE Hot Sheet
Trade RARE Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Ultragenyx Pharma (NASDAQ: RARE) reported Q2 EPS of ($1.46), $0.02 worse than the analyst estimate of ($1.44).

For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment